Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Michael Ybarra

Michael Ybarra is an emergency medicine physician and Chief Medical Officer at PhRMA.

Recent Posts

What you should know about RSV

By Michael Ybarra  |    November 15, 2022
You are probably reading a lot about a surge of cases of respiratory viruses like respiratory syncytial virus (RSV), influenza (the flu) and SARS-CoV-2, which causes COVID-19. The triple threat of...   Read More

Word of the Month: Long COVID

By Michael Ybarra  |    October 19, 2022
What is Long COVID?   Read More

Protecting against influenza: A conversation with David Ross, Vice President, Commercial Operations, North America, CSL Seqirus

By Michael Ybarra  |    October 13, 2022
Our industry is at the forefront of fighting the annual influenza virus. I recently had the chance to connect with David Ross, Vice President, Commercial Operations, North America, CSL Seqirus about...   Read More

Key takeaways from ASCO's annual meeting

By Michael Ybarra  |    June 10, 2022
Last weekend, health care professionals, patients, scientists and biopharmaceutical researchers gathered for the American Society of Clinical Oncology's (ASCO) annual meeting. With over 200 sessions...   Read More

Setting the record straight: Addressing common misconceptions about the COVID-19 vaccine

By Michael Ybarra  |    August 4, 2021
Bolstered by incredible progress in the fight against COVID-19, the biopharmaceutical industry continues to work around the clock to research, develop and manufacture vaccines and therapeutics to...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates